In 2022, Bruce Wale of Victoria, B.C. went to San Jose, Mexico as he had done many times before. But this time, he returned ...

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

Transgene, ProBioGen join forces to advance individualized cancer vaccine development: Strasbourg, France Thursday, November 7, 2024, 11:00 Hrs [IST] Transgene, a biotech company ...

myvac is a viral vector (MVA—Modified Vaccinia Ankara ... This virus-based therapeutic vaccine encodes neoantigens (patient-specific mutations) identified and selected by NEC’s Neoantigen Prediction ...

The triple challenge of raising awareness, changing behaviours, and standardising treatment approaches continues to demand ...

The Sabin Vaccine Institute, an American non-profit organization, has also donated 1,700 doses of the adenovirus-derived viral vector vaccine to Rwanda. The Rwandan government chose to prioritize ...

The growth in the Zika virus therapeutics market is driven by several factors, including the increasing global incidence of Zika outbreaks, the rising demand for preventive measures such as vaccines, ...